Search - tctmd.com

Displaying 1 - 20 of 48

Sort: Relevancy | Date

Presentation TCT 2024

Too Good to Be True? Five Top Lessons of Major GLP-1 Agonists Trials

Presenter: C. Michael Gibson

October 27, 2024

Presentation ESC 2024

BedMed and BedMed-Frail randomized controlled trials

Presenter: Scott Garrison

August 31, 2024

Presentation NY Valves 2024

Real World TTVI Registries: Is There Concordance With the Randomized Trials?

Presenter: Bassem M. Chehab

June 07, 2024

Presentation NY Valves 2024

T-TEER - TRILUMINATE

Presenter: Brian K. Whisenant

June 07, 2024

Presentation NY Valves 2024

Transcatheter Tricuspid Valve Replacement - TRISCEND II

Presenter: Raj Makkar

June 07, 2024

Presentation AHA 2023

Two Randomized Controlled Trials of Nudges to Encourage Referrals to Centralized Pharmacy Services for Evidence-Based Statin Initiation in High-Risk Patients: The SUPER LIPID Program

Presenter: Alexander C. Fanaroff

November 13, 2023

Presentation TCT 2023

TCT 158: The Impact of Sex And Age On Long-term Outcome After Percutaneous Coronary Interventions – A Pooled Analysis Of The Randomized Controlled SORT OUT Trials

Presenter: Emil Holck

October 26, 2023

Presentation TCT 2023

TCT 325: Changes in Blood Pressure after Crossover to Ultrasound Renal Denervation: Patient-Level Pooled Analysis of the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO and RADIANCE-HTN TRIO Trials

Presenter: Michael Bloch

October 25, 2023

Presentation TCT 2023

Hypertension Care Pathway with uRDN: Experiences from Clinical Trials

Presenter: NULL

October 25, 2023

Presentation TCT 2022

Update on the RADIANCE Clinical Trials Program (Ultra-Sound Renal Denervation)

Presenter: Naomi Fisher

September 17, 2022

Presentation TCT 2022

Update on the SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation)

Presenter: David Kandzari

September 17, 2022

Presentation TCT 2021

The SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation): Clinical Trials Status Update

Presenter: David E. Kandzari

November 04, 2021

Presentation TCT 2021

SUGAR: A Randomized Trial of Amphilimus-eluting Stents and Zotarolimus-eluting Stents in Patients With Diabetes

Presenter: Rafael Romaguera

November 04, 2021

Presentation TCT 2020

Industry Sponsors (Supporting Innovation and Medical Device Approval)

Presenter: Manuela Negoita

October 15, 2020

Presentation TCT 2019

Update on Target BP Trials Program (Chemical Renal Denervation): Lessons Learned, Ongoing Efforts

Presenter: Felix Mahfoud

September 28, 2019

Presentation TCT 2019

Update on RADIANCE Trials Program (Ultra-Sound Renal Denervation): Lessons Learned, Ongoing Efforts

Presenter: Ajay Kirtane

September 28, 2019

Presentation TCT 2019

Update on SPRYRAL Trials Program (Radiofrequency Renal Denervation): Lessons Learned, Ongoing Efforts

Presenter: Michael Boehm

September 28, 2019

Presentation ARCH 2019

Renal Denervation: Update of Trials

Presenter: Jason Fontana

April 12, 2019

Presentation CDM 2018

Cardiovascular Outcomes Trials (CVOT): Latest Results and Recommendations

Presenter: Dailey George

October 12, 2018

Presentation TCT 2018

Clinical Trials All Look Positive: Is Renal Denervation Ready for Clinical Practice Now?

Presenter: Felix Mahfoud, Krishna J. Rocha-Singh, Chandan Devireddy

September 24, 2018

Advertisement

Too Good to Be True? Five Top Lessons of Major GLP-1 Agonists Trials

BedMed and BedMed-Frail randomized controlled trials

Real World TTVI Registries: Is There Concordance With the Randomized Trials?

T-TEER - TRILUMINATE

Transcatheter Tricuspid Valve Replacement - TRISCEND II

Two Randomized Controlled Trials of Nudges to Encourage Referrals to Centralized Pharmacy Services for Evidence-Based Statin Initiation in High-Risk Patients: The SUPER LIPID Program

TCT 158: The Impact of Sex And Age On Long-term Outcome After Percutaneous Coronary Interventions – A Pooled Analysis Of The Randomized Controlled SORT OUT Trials

TCT 325: Changes in Blood Pressure after Crossover to Ultrasound Renal Denervation: Patient-Level Pooled Analysis of the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO and RADIANCE-HTN TRIO Trials

Hypertension Care Pathway with uRDN: Experiences from Clinical Trials

Update on the RADIANCE Clinical Trials Program (Ultra-Sound Renal Denervation)

Update on the SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation)

The SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation): Clinical Trials Status Update

SUGAR: A Randomized Trial of Amphilimus-eluting Stents and Zotarolimus-eluting Stents in Patients With Diabetes

Industry Sponsors (Supporting Innovation and Medical Device Approval)

Update on Target BP Trials Program (Chemical Renal Denervation): Lessons Learned, Ongoing Efforts

Update on RADIANCE Trials Program (Ultra-Sound Renal Denervation): Lessons Learned, Ongoing Efforts

Update on SPRYRAL Trials Program (Radiofrequency Renal Denervation): Lessons Learned, Ongoing Efforts

Renal Denervation: Update of Trials

Cardiovascular Outcomes Trials (CVOT): Latest Results and Recommendations

Clinical Trials All Look Positive: Is Renal Denervation Ready for Clinical Practice Now?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content